China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Forsakringsaktiebolaget Avanza Pension(1,29%)
China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Forsakringsaktiebolaget Avanza Pension(5,42%)
China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Forsakringsaktiebolaget Avanza Pension(2,38%)
China SXT Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Forsakringsaktiebolaget Avanza Pension(5,07%)
China SXT Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Streeterville Capital LLC(9.99*%),Streeterville Management LLC(9.99*%), etc.
China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Streeterville Capital LLC(0%),Streeterville Management LLC(0%), etc.
China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
China SXT Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Feng Zhou(21.498%),Zhijun Xiao(20.179%)
China SXT Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Streeterville Capital LLC(9.99*%),Streeterville Management LLC(9.99*%), etc.
China SXT Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(9.9%),Lind Global Fund II LLC(9.9%), etc.
China SXT Pharmaceuticals | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
China SXT Pharmaceuticals | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
China SXT Pharmaceuticals | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
China SXT Pharmaceuticals | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
China SXT Pharmaceuticals | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
China SXT Pharmaceuticals | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
No Data